Gunnar J. Hanson

Health Technology

Consumer Services

Finance

Profile

Gunnar J.
Hanson worked as a Senior Director-Research Chemistry at Sarepta Therapeutics, Inc., a Principal at Pfizer Inc. and Serenex, Inc., and as a Vice President-Chemistry at Joyant Pharmaceuticals, Inc. He holds a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from the University of Oregon.

Former positions of Gunnar J. Hanson

Companies	Position	End
SAREPTA THERAPEUTICS, INC.	Corporate Officer/Principal	-
Serenex, Inc. Serenex, Inc. Pharmaceuticals: MajorHealth Technology Serenex, Inc. operates as a biotechnology company that develops drugs for tumors and cancers of the blood and bone marrow. Its products include drugs for chemotherapy treatments as well as inhibitor compounds. Serenex was founded by George Young and Timothy Haystead in 2000 and is headquartered in Durham, NC.	Corporate Officer/Principal	-
PFIZER, INC.	Corporate Officer/Principal	-
Joyant Pharmaceuticals, Inc. Joyant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Joyant Pharmaceuticals is a Dallas-based drug discovery company focused on the development of small molecule therapeutics for cancer. Their core competencies include chemical synthesis biochemistry, cell biology, and pharmacology. The focus of its company is on the development of unique chemical entities that operate by new cellular mechanisms. Its understanding of the molecular events that control the growth, replication, and apoptosis of human cells is becoming increasingly sophisticated. They intend to translate new knowledge of such pathways, and their misregulation in disease, into signaling-based targeted therapeutics.	Corporate Officer/Principal	-

See the detail of Gunnar J. Hanson's experience

Training of Gunnar J. Hanson

University of Oregon	Undergraduate Degree
Massachusetts Institute of Technology	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies